|
1
|
Bollschweiler E, Plum P, Mönig SP and
Hölscher AH: Current and future treatment options for esophageal
cancer in the elderly. Expert Opin Pharmacother. 18:1001–1010.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simard EP, Ward EM, Siegel R and Jemal A:
Cancers with increasing incidence trends in the United States: 1999
through 2008. CA Cancer J Clin. 62:118–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang FL and Yu SJ: Esophageal cancer:
Risk factors, genetic association, and treatment. Asian J Surg.
41:210–215. 2018. View Article : Google Scholar
|
|
5
|
He X, Meng F, Qin L, Liu Z, Zhu X, Yu Z
and Zheng Y: KLK11 suppresses cellular proliferation via inhibition
of Wnt/β-catenin signaling pathway in esophageal squamous cell
carcinoma. Am J Cancer Res. 9:2264–2277. 2019.
|
|
6
|
Deng H, Shi H, Chen L, Zhou Y and Jiang J:
Over-expression of Nectin-4 promotes progression of esophageal
cancer and correlates with poor prognosis of the patients. Cancer
Cell Int. 19:1062019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hneino M, François A, Buard V, Tarlet G,
Abderrahmani R, Blirando K, Hoodless P, Benderitter M and Milliat
F: The TGF-β/Smad repressor TG-Interacting factor 1 (TGIF1) plays a
role in radiation-induced intestinal injury independently of a Smad
signaling pathway. PLoS One. 7:e356722012. View Article : Google Scholar
|
|
8
|
Guca E, Suñol D, Ruiz L, Konkol A, Cordero
J, Torner C, Aragon E, Martin-Malpartida P, Riera A and Macias MJ:
TGIF1 homeodomain interacts with Smad MH1 domain and represses
TGF-β signaling. Nucleic Acids Res. 46:9220–9235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Razzaque MS and Atfi A: TGIF function in
oncogenic Wnt signaling. Biochim Biophys Acta. 1865:101–104.
2016.
|
|
10
|
Zhang MZ, Ferrigno O, Wang Z, Ohnishi M,
Prunier C, Levy L, Razzaque M, Horne WC, Romero D, Tzivion G, et
al: TGIF governs a feed-forward network that empowers Wnt signaling
to drive mammary tumorigenesis. Cancer Cell. 27:547–560. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shah A, Melhuish TA, Fox TE, Frierson HF
Jr and Wotton D: TGIF transcription factors repress acetyl CoA
metabolic gene expression and promote intestinal tumor growth.
Genes Dev. 33:388–402. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiang G, Yi Y, Weiwei H and Weiming W:
TGIF1 promoted the growth and migration of cancer cells in nonsmall
cell lung cancer. Tumour Biol. 36:9303–9310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Li L, Wang H, Li J and Yang H:
Silencing TGIF suppresses migration, invasion and metastasis of
MDA-MB-231 human breast cancer cells. Oncol Rep. 39:802–808.
2018.
|
|
14
|
Wang JL, Qi Z, Li YH, Zhao HM, Chen YG and
Fu W: TGFβ induced factor homeobox 1 promotes colorectal cancer
development through activating Wnt/β-catenin signaling. Oncotarget.
8:70214–70225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Pan T, Li L, Wang H, Li J, Zhang D
and Yang H: Knockdown of TGIF attenuates the proliferation and
tumorigenicity of EC109 cells and promotes cisplatin-induced
apoptosis. Oncol Lett. 14:6519–6524. 2017.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sang LJ, Ju HQ, Liu GP, Tian T, Ma GL, Lu
YX, Liu ZX, Pan RL, Li RH, Piao HL, et al: LncRNACamK-A Regulates
Ca(2+)-signaling-mediated tumor microenvironment remodeling. Mol
Cell. 72:71–83.e7. 2018. View Article : Google Scholar
|
|
19
|
Yang T, Huang T, Zhang D, Wang M, Wu B,
Shang Y, Sattar S and Ding L: TGF-β receptor inhibitor LY2109761
enhances the radiosensitivity of gastric cancer by inactivating the
TGF-β/SMAD4 signaling pathway. Aging (Albany NY). 11:8892–8910.
2019. View Article : Google Scholar
|
|
20
|
Yu Y, Li X, Liu J, Dong M and Xing L:
Correlation of hypoxia status with radiosensitizing effects of
sodium glycididazole: A preclinical study. Oncol Lett.
15:6481–6488. 2018.PubMed/NCBI
|
|
21
|
Yu Y, Guan H, Jiang L, Li X, Xing L and
Sun X: Nimotuzumab, an EGFR-targeted antibody, promotes
radiosensitivity of recurrent esophageal squamous cell carcinoma.
Int J Onco. l56:945–956. 2020.
|
|
22
|
Jia K, Wen QH, Zhao X, Cheng JM, Cheng L
and Xi M: XTP8 stimulates migration and invasion of gastric
carcinoma through interacting with TGIF1. Eur Rev Med Pharmacol
Sci. 24:2412–2420. 2020.PubMed/NCBI
|
|
23
|
Haider MT, Saito H, Zarrer J,
Uzhunnumpuram K, Nagarajan S, Kari V, Horn-Glander M, Werner S,
Hesse E and Taipaleenmäki H: Breast cancer bone metastases are
attenuated in a Tgif1-deficient bone microenvironment. Breast
Cancer Res. 22:342020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parajuli P, Singh P, Wang Z, Li L,
Eragamreddi S, Ozkan S, Ferrigno O, Prunier C, Razzaque MS, Xu K
and Atfi A: TGIF1 functions as a tumor suppressor in pancreatic
ductal adenocarcinoma. EMBO J. 38:e1010672019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weng CC, Hsieh MJ, Wu CC, Lin YC, Shan YS,
Hung WC, Chen LT and Cheng KH: Loss of the transcriptional
repressor TGIF1 results in enhanced Kras-driven development of
pancreatic cancer. Mol Cancer. 18:962019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sha Y, Haensel D, Gutierrez G, Du H, Dai X
and Nie Q: Intermediate cell states in epithelial-to-mesenchymal
transition. Phys Biol. 16:0210012019. View Article : Google Scholar :
|
|
27
|
Aiello NM and Kang Y: Context-dependent
EMT programs in cancer metastasis. J Exp Med. 216:1016–1026. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Campbell K: Contribution of
epithelial-mesenchymal transitions to organogenesis and cancer
metastasis. Curr Opin Cell Biol. 55:30–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van Staalduinen J, Baker D, Ten Dijke P
and Van Dam H: Epithelial-mesenchymal-transition-inducing
transcription factors: New targets for tackling chemoresistance in
cancer? Oncogene. 37:6195–6211. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kalluri R: EMT: When epithelial cells
decide to become mesenchymal-like cells. J Clin Invest.
119:1417–1419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127(Pt 3): 469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hoppler S and Kavanagh CL: Wnt signalling:
Variety at the core. J Cell Sci. 120:385–393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Clevers H and Nusse R: Wnt/beta-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang Z, Shah K, Busby T, Giles K,
Khodadadi-Jamayran A, Li W and Jiang H: Hijacking a key chromatin
modulator creates epigenetic vulnerability for MYC-driven cancer. J
Clin Invest. 128:3605–3618. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dejure FR and Eilers M: MYC and tumor
metabolism: Chicken and egg. EMBO J. 36:3409–3420. 2017. View Article : Google Scholar : PubMed/NCBI
|
